Skip to content
SEARCH icon
  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeHealth

      Health

      The Ensign Group Reports Second Quarter 2026 Results
      Health

      The Ensign Group Reports Second Quarter 2026 Results

      July 27, 2026
      RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
      Health

      RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

      July 27, 2026
      Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
      Health

      Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026

      July 27, 2026
      ARCPOINT PROVIDES LEADERSHIP UPDATE
      Health

      ARCPOINT PROVIDES LEADERSHIP UPDATE

      July 25, 2026
      PRINCIPAL TECHNOLOGIES CLOSES PRIVATE PLACEMENT FINANCING
      Health

      PRINCIPAL TECHNOLOGIES CLOSES PRIVATE PLACEMENT FINANCING

      July 25, 2026
      CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
      Health

      CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)

      July 24, 2026
      MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
      Health

      MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease

      July 24, 2026
      MannKind Announces $50 Million Private Placement
      Health

      MannKind Announces $50 Million Private Placement

      July 24, 2026
      Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call
      Health

      Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call

      July 23, 2026
      West Reports Second-Quarter 2026 Results
      Health

      West Reports Second-Quarter 2026 Results

      July 23, 2026
      « 1 … 6 7 8 9 10 … 83 »

       

      LATEST NEWS

      • Investing Best Dividend Stock if the Bank of Canada Cuts Rates
      • Investing News Can This Undervalued Stock Make You a Millionaire?
      • Investing News High Dividend Yield Stocks for Passive Income: Fiera Capital
      • Investing Top Canadian ETFs to Buy and Hold in Your TFSA

      Trading Whisperer

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Trading Whisperer.

      I want e-mail alerts, updates, and offers and agree to the Trading Whisperer privacy policy.

      Market Jar Media Inc. © 2026